Physician
Franciscan Health Indianapolis & Mooresville
Franciscan Health Indianapolis & Mooresville was paid $12.35M by Medicaid between Jan 2018 and Dec 2024, across 60 billing codes. Its largest line is 99283, emergency room visit (moderate) — 37% of everything it billed.
33Billing provider infoFRANCISCAN HEALTH INDIANAPOLIS & MOORESVILLE
MOORESVILLE, IN 46158
MOORESVILLE, IN 46158
33aNPI1679678197assigned 09/13/2006
33bProvider typeFamily Medicine Physician
28Total paid$12.35M
24GClaims166,763
24DCodes billed60
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Indiana
Rank by total paid#3 of 408
Median peer was paid$81K
This provider vs. median152×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,184 | $536K | |
| 2019 | 13,958 | $1.08M | |
| 2020 | 13,795 | $1.07M | |
| 2021 | 23,252 | $1.99M | |
| 2022 | 32,664 | $2.64M | |
| 2023 | 36,861 | $2.78M | |
| 2024incomplete | 28,049 | $2.25M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 37% | 32,066 | 28,170 | $4.57M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 31% | 22,967 | 19,194 | $3.80M |
| 71045 | Radiologic examination, chest; single view | 4.4% | 3,565 | 3,018 | $548K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.2% | 3,449 | 3,177 | $513K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4.1% | 7,369 | 6,005 | $512K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.4% | 3,246 | 2,648 | $423K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.6% | 4,569 | 3,885 | $320K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.6% | 7,863 | 6,572 | $194K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.5% | 5,217 | 1,767 | $180K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.1% | 3,132 | 2,557 | $140K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.1% | 338 | 276 | $133K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.0% | 2,984 | 2,562 | $125K |
48 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 20,739 | $111K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,317 | $107K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,209 | $102K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 717 | $78K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,084 | $72K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 11,588 | $63K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,542 | $55K |
| 73562 | <1% | 1,730 | $48K | |
| 97161 | <1% | 522 | $44K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,496 | $34K |
| 95806 | <1% | 36 | $23K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 447 | $19K |
| 81001 | <1% | 7,780 | $18K | |
| 97162 | <1% | 212 | $17K | |
| 80053 | Comprehensive metabolic panel | <1% | 2,307 | $17K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 529 | $13K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 97 | $12K |
| 84484 | <1% | 1,333 | $11K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 339 | $7K |
| 73564 | <1% | 104 | $5K | |
| 97113 | <1% | 132 | $4K | |
| 83690 | <1% | 1,045 | $4K | |
| 80076 | <1% | 623 | $4K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 105 | $4K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 50 | $4K |
| 84703 | <1% | 581 | $4K | |
| 81025 | <1% | 720 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 163 | $3K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 69 | $3K |
| 73502 | <1% | 60 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 43 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 247 | $932.31 |
| 80061 | Lipid panel | <1% | 81 | $717.07 |
| 87276 | <1% | 77 | $390.71 | |
| 87275 | <1% | 77 | $354.80 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 22 | $307.01 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 14 | $219.24 |
| 84702 | <1% | 12 | $124.09 | |
| 83605 | <1% | 16 | $114.51 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 33 | $84.06 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 33 | $84.06 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 278 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 149 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 52 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 2,074 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 55 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 47 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHERRON, AMY (DIVISIONAL CFO)
| Provider | Location | Paid |
|---|---|---|
| Franciscan Health Indianapolis & Mooresville | Indianapolis, IN | $41.36M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.